Literature DB >> 6138602

Haematological and biochemical monitoring of Ebola infection in rhesus monkeys: implications for patient management.

S P Fisher-Hoch, G S Platt, G Lloyd, D I Simpson, G H Neild, A J Barrett.   

Abstract

Patients with severe viral infections such as Lassa or Ebola may be denied adequate laboratory investigations because of justifiable fears among laboratory staff. This study in monkeys was designed to provide comprehensive haematological and biochemical monitoring in a contained environment during all stages of Ebola infection. Marked neutrophilia, depletion of lymphocytes, and early failure of platelet aggregation preceded a consumption coagulopathy with a microangiopathic haemolytic anaemia, thrombocytopenia, and failure of prostacyclin production by vascular endothelium. Liver dysfunction was moderate but in conjunction with the dehydration and hypoalbuminaemia could be expected to precipitate renal failure and shock. It seems reasonable to anticipate successful patient support with a patient management isolator and treatment with platelet transfusions, fresh frozen plasma, and possibly prostacyclin when haemostasis is defective during this otherwise self-limiting illness.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6138602     DOI: 10.1016/s0140-6736(83)91041-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  26 in total

1.  Infection and activation of monocytes by Marburg and Ebola viruses.

Authors:  U Ströher; E West; H Bugany; H D Klenk; H J Schnittler; H Feldmann
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

2.  Host response dynamics following lethal infection of rhesus macaques with Zaire ebolavirus.

Authors:  Hideki Ebihara; Barry Rockx; Andrea Marzi; Friederike Feldmann; Elaine Haddock; Douglas Brining; Rachel A LaCasse; Don Gardner; Heinz Feldmann
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

3.  Advanced antisense therapies for postexposure protection against lethal filovirus infections.

Authors:  Travis K Warren; Kelly L Warfield; Jay Wells; Dana L Swenson; Kelly S Donner; Sean A Van Tongeren; Nicole L Garza; Lian Dong; Dan V Mourich; Stacy Crumley; Donald K Nichols; Patrick L Iversen; Sina Bavari
Journal:  Nat Med       Date:  2010-08-22       Impact factor: 53.440

4.  Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus.

Authors:  E Johnson; N Jaax; J White; P Jahrling
Journal:  Int J Exp Pathol       Date:  1995-08       Impact factor: 1.925

5.  Vaccinating captive chimpanzees to save wild chimpanzees.

Authors:  Kelly L Warfield; Jason E Goetzmann; Julia E Biggins; Mary Beth Kasda; Robert C Unfer; Hong Vu; M Javad Aman; Gene Gerrard Olinger; Peter D Walsh
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-27       Impact factor: 11.205

6.  Demonstration of cross-protective vaccine immunity against an emerging pathogenic Ebolavirus Species.

Authors:  Lisa E Hensley; Sabue Mulangu; Clement Asiedu; Joshua Johnson; Anna N Honko; Daphne Stanley; Giulia Fabozzi; Stuart T Nichol; Thomas G Ksiazek; Pierre E Rollin; Victoria Wahl-Jensen; Michael Bailey; Peter B Jahrling; Mario Roederer; Richard A Koup; Nancy J Sullivan
Journal:  PLoS Pathog       Date:  2010-05-20       Impact factor: 6.823

7.  Experimental respiratory Marburg virus haemorrhagic fever infection in the common marmoset (Callithrix jacchus).

Authors:  Sophie J Smither; Michelle Nelson; Lin Eastaugh; Thomas R Laws; Christopher Taylor; Simon A Smith; Francisco J Salguero; Mark S Lever
Journal:  Int J Exp Pathol       Date:  2013-02-27       Impact factor: 1.925

Review 8.  Post-exposure treatments for Ebola and Marburg virus infections.

Authors:  Robert W Cross; Chad E Mire; Heinz Feldmann; Thomas W Geisbert
Journal:  Nat Rev Drug Discov       Date:  2018-01-29       Impact factor: 84.694

9.  Disease modeling for Ebola and Marburg viruses.

Authors:  Dennis Bente; Jason Gren; James E Strong; Heinz Feldmann
Journal:  Dis Model Mech       Date:  2009 Jan-Feb       Impact factor: 5.758

10.  Development and characterization of a mouse model for Marburg hemorrhagic fever.

Authors:  Kelly L Warfield; Steven B Bradfute; Jay Wells; Loreen Lofts; Meagan T Cooper; D Anthony Alves; Daniel K Reed; Sean A VanTongeren; Christine A Mech; Sina Bavari
Journal:  J Virol       Date:  2009-04-15       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.